Regional brain hypometabolism is unrelated to regional amyloid plaque burden

In its original form, the amyloid cascade hypothesis of Alzheimer's disease holds that fibrillar deposits of amyloid are an early, driving force in pathological events leading ultimately to neuronal death. Early clinicopathological investigations highlighted a number of inconsistencies leading to an updated hypothesis in which amyloid plaques give way to amyloid oligomers as the driving force in pathogenesis. Rather than focusing on the inconsistencies, amyloid imaging studies have tended to highlight the overlap between regions that show early amyloid plaque signal on positron emission tomography and that also happen to be affected early in Alzheimer's disease. Recent imaging studies investigating the regional dependency between metabolism and amyloid plaque deposition have arrived at conflicting results, with some showing regional associations and other not. We extracted multimodal neuroimaging data from the Alzheimer's disease neuroimaging database for 227 healthy controls and 434 subjects with mild cognitive impairment. We analysed regional patterns of amyloid deposition, regional glucose metabolism and regional atrophy using florbetapir ((18)F) positron emission tomography, (18)F-fluordeoxyglucose positron emission tomography and T1-weighted magnetic resonance imaging, respectively. Specifically, we derived grey matter density and standardized uptake value ratios for both positron emission tomography tracers in 404 functionally defined regions of interest. We examined the relation between regional glucose metabolism and amyloid plaques using linear models. For each region of interest, correcting for regional grey matter density, age, education and disease status, we tested the association of regional glucose metabolism with (i) cortex-wide florbetapir uptake; (ii) regional (i.e. in the same region of interest) florbetapir uptake; and (iii) regional florbetapir uptake while correcting in addition for cortex-wide florbetapir uptake. P-values for each setting were Bonferroni corrected for 404 tests. Regions showing significant hypometabolism with increasing cortex-wide amyloid burden were classic Alzheimer's disease-related regions: the medial and lateral parietal cortices. The associations between regional amyloid burden and regional metabolism were more heterogeneous: there were significant hypometabolic effects in posterior cingulate, precuneus, and parietal regions but also significant positive associations in bilateral hippocampus and entorhinal cortex. However, after correcting for global amyloid burden, few of the negative associations remained and the number of positive associations increased. Given the wide-spread distribution of amyloid plaques, if the canonical cascade hypothesis were true, we would expect wide-spread, cortical hypometabolism. Instead, cortical hypometabolism appears to be linked to global amyloid burden. Thus we conclude that regional fibrillar amyloid deposition has little to no association with regional hypometabolism

A tutorial on multi-view autoencoders using the multi-view-AE library

There has been a growing interest in recent years in modelling multiple modalities (or views) of data to for example, understand the relationship between modalities or to generate missing data. Multi-view autoencoders have gained significant traction for their adaptability and versatility in modelling multi-modal data, demonstrating an ability to tailor their approach to suit the characteristics of the data at hand. However, most multi-view autoencoders have inconsistent notation and are often implemented using different coding frameworks. To address this, we present a unified mathematical framework for multi-view autoencoders, consolidating their formulations. Moreover, we offer insights into the motivation and theoretical advantages of each model. To facilitate accessibility and practical use, we extend the documentation and functionality of the previously introduced \texttt{multi-view-AE} library. This library offers Python implementations of numerous multi-view autoencoder models, presented within a user-friendly framework. Through benchmarking experiments, we evaluate our implementations against previous ones, demonstrating comparable or superior performance. This work aims to establish a cohesive foundation for multi-modal modelling, serving as a valuable educational resource in the field

Modulatory neurotransmitter genotypes shape dynamic functional connectome reconfigurations

Dynamic reconfigurations of the functional connectome across different connectivity states are highly heritable, predictive of cognitive abilities, and linked to mental health. Despite their established heritability, the specific polymorphisms that shape connectome dynamics are largely unknown. Given the widespread regulatory impact of modulatory neurotransmitters on functional connectivity, we comprehensively investigated a large set of single nucleotide polymorphisms (SNPs) of their receptors, metabolic enzymes, and transporters in 674 healthy adult subjects (347 females) from the Human Connectome Project. Pre-registered modulatory neurotransmitter SNPs and dynamic connectome features entered a Stability Selection procedure with resampling. We found that specific subsets of these SNPs explain individual differences in temporal phenotypes of fMRI-derived connectome dynamics for which we previously established heritability. Specifically, noradrenergic polymorphisms explained Fractional Occupancy, i.e., the proportion of time spent in each connectome state, and cholinergic polymorphisms explained Transition Probability, i.e., the probability to transition between state pairs, respectively. This work identifies specific genetic effects on connectome dynamics via the regulatory impact of modulatory neurotransmitter systems. Our observations highlight the potential of dynamic connectome features as endophenotypes for neurotransmitter-focused precision psychiatry

Solar Neutrino Rates, Spectrum, and its Moments : an MSW Analysis in the Light of Super-Kamiokande Results

We re-examine MSW solutions of the solar neutrino problem in a two flavor scenario taking (a) the results on total rates and the electron energy spectrum from the 1117-day SuperKamiokande (SK) data and (b) those on total rates from the Chlorine and Gallium experiments. We find that the SMA solution gives the best fit to the total rates data from the different experiments. One new feature of our analysis is the use of the moments of the SK electron spectrum in a $\chi^2$ analysis. The best-fit to the moments is broadly in agreement with that obtained from a direct fit to the spectrum data and prefers a $\Delta m^2$ comparable to the SMA fit to the rates but the required mixing angle is larger. In the combined rate and spectrum analysis, apart from varying the normalization of the $^8$B flux as a free parameter and determining its best-fit value we also obtain the best-fit parameters when correlations between the rates and the spectrum data are included and the normalization of the $^8$B flux held fixed at its SSM value. We observe that the correlations between the rates and spectrum data are important and the goodness of fit worsens when these are included. In either case, the best-fit lies in the LMA region.Comment: 17 pages, 4 figure

Mining genetic, transcriptomic, and imaging data in Parkinson’s disease

Parkinson’s disease (PD) is a brain disorder that leads to shaking, stiffness and difficulties with walking, balance, and coordination. Affected people may also have mental and behavioral changes, sleep problems, depression, memory difficulties and fatigue. PD is an age-related disease, with an increased prevalence in populations of subjects over the age of 60. About 5 to 10% of PD patients have an "early-onset" variant and it is often, but not always, inherited. PD is characterized by the loss of groups of neurons involved in the control of voluntary movements. Here we present a novel imaging-genetics workflow on Parkinson’s disease aimed to discover some new potential candidate biomarkers for Parkinson’s disease onset, by interpolating genotyping, transcriptomic, functional (Dopamine Transporter Scan) and morphological (Magnetic Resonance Imaging) imaging data. The proposed tutorial has the aim to encourage and stimulate the attendees on the biomedical research with the advantage of integration of heterogenous data. In the last decade the use of images together with genetics data has become widespread among the bioinformatics researchers. This has allowed to inspect and investigate in detail different specific diseases, to better understand their origin and cause. While in recent years many imaging genetics analyses have been developed and successfully applied to characterize brain functioning and neurodegenerative diseases such as Alzheimer’s disease, to our knowledge, no standard imaging genetics workflow has been proposed for PD. The novelty of our workflow can be summarized as follows: • We propose a domain free and easy-to-use workflow, integrating heterogenous data, such as genotyping, transcriptomic, and imaging data. • The workflow addresses the complexity of integrating real multi-source data when a limited number of data are available by proposing three step-based method, where the first step integrates genotyping and imaging features considering each feature individually, the second step summarizes imaging features in a single measure, and the last step focuses on linking potential functional effects caused by the biomarkers found during the two previous phases. • We propose a validation of the method on genetic and imaging data related to PD, showing our new results. The data used for this tutorial were obtained from the Parkinson’s Progression Marker Initiative (PPMI) data portal. Currently, PPMI is the most complete and comprehensive collection of PD-related data. The dataset that will be used in the tutorial consists in a set of polymorphisms, more specifically insertions and deletions (indels) or Single Nucleotide Polymorphisms (SNPs), and transcriptomic data retrieved by RNA sequencing. In addition, DaTSCAN and MRI data are used, which have been shown to be effective in providing potential biomarkers for PD onset and progression. The attendees will acquire an experience on how to conduct a complete imaging-genetics workflow, in a specific case study of Parkinsonian subjects. After the tutorial session the attendees will be able to conduct themselves an imaging-genetics pipeline, which could also be applied to study other neurological diseases. The tutorial will introduce the partecipants to the biological background, especially with the notion of DNA, RNA, Single-nucleotide polymorphism (SNP) and Genome-Wide Association Study (GWAS). The participants will have the opportunity to get familiar with PLINK, a free, open-source whole genome association analysis toolset, designed to perform a range of basic, large-scale analyzes in a computationally efficient manner. It provides a large range of functionalities designed for data management, summary statistics, quality control, population stratification detection, association analysis, etc. for genotyping data analysis. The audience will also learn how to run code on the widely used R programming environment for statistical computing and graphics. They will also learn some notions about Python, especially how to deal efficiently, with genotyping data using Pandas library, which was designed for data manipulation and analysis. The tutorial code is wrapped in different Jupyter notebooks (formerly IPython Notebooks), that is a web-based and system-independent interactive computational environment for easy analysis reproducibility

Dynamic trajectories of connectome state transitions are heritable

The brain's functional connectome is dynamic, constantly reconfiguring in an individual-specific manner. However, which characteristics of such reconfigurations are subject to genetic effects, and to what extent, is largely unknown. Here, we identified heritable dynamic features, quantified their heritability, and determined their association with cognitive phenotypes. In resting-state fMRI, we obtained multivariate features, each describing a temporal or spatial characteristic of connectome dynamics jointly over a set of connectome states. We found strong evidence for heritability of temporal features, particularly, Fractional Occupancy (FO) and Transition Probability (TP), representing the duration spent in each connectivity configuration and the frequency of shifting between configurations, respectively. These effects were robust against methodological choices of number of states and global signal regression. Genetic effects explained a substantial proportion of phenotypic variance of these features (h2=0.39, 95% CI= [.24,.54] for FO; h2=0.43, 95% CI=[.29,.57] for TP). Moreover, these temporal phenotypes were associated with cognitive performance. Contrarily, we found no robust evidence for heritability of spatial features of the dynamic states (i.e., states’ Modularity and connectivity pattern). Genetic effects may therefore primarily contribute to how the connectome transitions across states, rather than the precise spatial instantiation of the states in individuals. In sum, genetic effects impact the dynamic trajectory of state transitions (captured by FO and TP), and such temporal features may act as endophenotypes for cognitive abilities

Re-Annotator: Annotation Pipeline for Microarray Probe Sequences

Microarray technologies are established approaches for high throughput gene expression, methylation and genotyping analysis. An accurate mapping of the array probes is essential to generate reliable biological findings. However, manufacturers of the microarray platforms typically provide incomplete and outdated annotation tables, which often rely on older genome and transcriptome versions that differ substantially from up-to-date sequence databases. Here, we present the Re-Annotator, a re-annotation pipeline for microarray probe sequences. It is primarily designed for gene expression microarrays but can also be adapted to other types of microarrays. The Re-Annotator uses a custom-built mRNA reference database to identify the positions of gene expression array probe sequences. We applied Re-Annotator to the Illumina Human-HT12 v4 microarray platform and found that about one quarter (25%) of the probes differed from the manufacturer's annotation. In further computational experiments on experimental gene expression data, we compared Re-Annotator to another probe re-annotation tool, ReMOAT, and found that Re-Annotator provided an improved re-annotation of microarray probes. A thorough re-annotation of probe information is crucial to any microarray analysis. The Re-Annotator pipeline is freely available at http://sourceforge.net/projects/reannotator along with re-annotated files for Illumina microarrays HumanHT-12 v3/v4 and MouseRef-8 v2

Leukocyte Telomere Length and Cardiac Structure and Function: A Mendelian Randomization Study

BACKGROUND: Existing research demonstrates the association of shorter leukocyte telomere length with increased risk of agerelated health outcomes including cardiovascular diseases. However, the direct causality of these relationships has not been definitively established. Cardiovascular aging at an organ level may be captured using image-derived phenotypes of cardiac anatomy and function. METHODS AND RESULTS: In the current study, we use 2-sample Mendelian randomization to assess the causal link between leukocyte telomere length and 54 cardiac magnetic resonance imaging measures representing structure and function across the 4 cardiac chambers. Genetically predicted shorter leukocyte telomere length was causally linked to smaller ventricular cavity sizes including left ventricular end-systolic volume, left ventricular end-diastolic volume, lower left ventricular mass, and pulmonary artery. The association with left ventricular mass (β =0.217, Pfalse discovery rate =0.016) remained significant after multiple testing adjustment, whereas other associations were attenuated. CONCLUSIONS: Our findings support a causal role for shorter leukocyte telomere length and faster cardiac aging, with the most prominent relationship with left ventricular mass